HISTAMINE-RELEASING PROPERTIES OF HYDROXY-9-METHYL-2-ELLIPTICINIUM ACETATE

被引：8
|
作者：
ESCHALIER, A
ADVENIER, C
LEBEL, B
BURTIN, C
LAVARENNE, J
机构：
[1] FAC MED NECKER ENFANTS MALADES, PHARMACOL LAB, F-75015 PARIS, FRANCE
[2] FAC MED NECKER ENFANTS MALADES, PATHOL EXPTL LAB, INSERM, FORMAT RECH 3, F-75015 PARIS, FRANCE
来源：
CANCER CHEMOTHERAPY AND PHARMACOLOGY | 1981年 / 5卷 / 04期
关键词：
D O I：
10.1007/BF00434390
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：233 / 236
页数：4
相关论文
共 50 条
  • [41] DRUG DEPENDENT RED-CELL ANTIBODIES AND INTRAVASCULAR HEMOLYSIS OCCURRING IN PATIENTS TREATED WITH 9 HYDROXY-METHYL-ELLIPTICINIUM
    CRIEL, AM
    HIDAJAT, M
    CLARYSSE, A
    VERWILGHEN, RL
    BRITISH JOURNAL OF HAEMATOLOGY, 1980, 46 (04) : 549 - 556
  • [42] PHASE I TRIAL OF 9-HYDROXY 2N-METHYL ELLIPTICINIUM (HME, NSC-264137) WITH A 5-DAY SCHEDULE
    DODION, P
    ROZENCWEIG, M
    NICAISE, C
    PICCART, M
    CRESPEIGNE, N
    VANRYMENANT, M
    KISNER, D
    KENIS, Y
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1982, 23 (MAR): : 151 - 151
  • [43] ALLERGIC RHINITIS TO RAGWEED POLLEN .2. MODULATION OF HISTAMINE-RELEASING FACTOR PRODUCTION BY SPECIFIC IMMUNOTHERAPY
    BRUNET, C
    BEDARD, PM
    LAVOIE, A
    JOBIN, M
    HEBERT, J
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1992, 89 (01) : 87 - 94
  • [44] INTERACTION OF NUCLEOSIDES WITH ANTITUMORAL AGENTS - 9-HYDROXY-N-2-METHYLELLIPTICINIUM ACETATE AND 9-HYDROXY-N-2-METHYLOLIVACINIUM ACETATE
    KANSAL, VK
    FUNAKOSHI, S
    MANGENEY, P
    GILLET, B
    GUITTET, E
    LALLEMAND, JY
    POTIER, P
    TETRAHEDRON, 1985, 41 (22) : 5107 - 5120
  • [45] PHYSICOCHEMICAL AND PHARMACOLOGICAL PROPERTIES OF THE ANTITUMOR ELLIPTICINE DERIVATIVE 2-(DIETHYLAMINO-2-ETHYL)9-HYDROXY ELLIPTICINIUM-CHLORIDE, HCL
    AUCLAIR, C
    PIERRE, A
    VOISIN, E
    PEPIN, O
    CROS, S
    COLAS, C
    SAUCIER, JM
    VERSCHUERE, B
    GROS, P
    PAOLETTI, C
    CANCER RESEARCH, 1987, 47 (23) : 6254 - 6261
  • [46] ENDOCRINE EFFECTS AND PHARMACOKINETIC CHARACTERISTICS OF A POTENT NEW GONADOTROPIN-RELEASING-HORMONE ANTAGONIST (GANIRELIX) WITH MINIMAL HISTAMINE-RELEASING PROPERTIES - STUDIES IN POSTMENOPAUSAL WOMEN
    RABINOVICI, J
    ROTHMAN, P
    MONROE, SE
    NERENBERG, C
    JAFFE, RB
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1992, 75 (05) : 1220 - 1225
  • [47] SUPPRESSION OF FOLLICULAR PHASE PITUITARY-GONADAL FUNCTION BY A POTENT NEW GONADOTROPIN-RELEASING-HORMONE ANTAGONIST WITH REDUCED HISTAMINE-RELEASING PROPERTIES (GANIRELIX)
    NELSON, LR
    FUJIMOTO, VY
    JAFFE, RB
    MONROE, SE
    FERTILITY AND STERILITY, 1995, 63 (05) : 963 - 969
  • [48] 9-HYDROXY-5,11-DIMETHYL-6N-METHYL-PYRIDO [3,4-B] CARBAZOLIUM CHLORIDE (6N-METHYL-9-HYDROXY ELLIPTICINIUM CHLORIDE), C18H16N2.HCL
    COURSEILLE, C
    BUSETTA, B
    HOSPITAL, M
    CRYSTAL STRUCTURE COMMUNICATIONS, 1982, 11 (03): : 897 - 900
  • [49] The increase in plasma matrix metalloproteinase-9 in patients with chronic urticaria is associated with disease severity but not with the presence of circulating histamine-releasing factors
    Tedeschi, A.
    Garattini, E.
    Loriniv, M.
    Cugno, M.
    Asero, R.
    ALLERGY, 2008, 63 : 47 - 47
  • [50] Src homology 2 domain-containing inositol 5′ phosphatase is negatively associated with histamine release to human recombinant histamine-releasing factor in human basophils
    Vonakis, BM
    Gibbons, S
    Sora, R
    Langdon, JM
    MacDonald, SM
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2001, 108 (05) : 822 - 831
12345